Ann Williams

6.2k total citations · 1 hit paper
104 papers, 4.4k citations indexed

About

Ann Williams is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Ann Williams has authored 104 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Infectious Diseases, 54 papers in Epidemiology and 50 papers in Immunology. Recurrent topics in Ann Williams's work include Tuberculosis Research and Epidemiology (70 papers), Mycobacterium research and diagnosis (43 papers) and Immune responses and vaccinations (23 papers). Ann Williams is often cited by papers focused on Tuberculosis Research and Epidemiology (70 papers), Mycobacterium research and diagnosis (43 papers) and Immune responses and vaccinations (23 papers). Ann Williams collaborates with scholars based in United Kingdom, United States and France. Ann Williams's co-authors include Philip D. Marsh, Simon Clark, Graham Hatch, Helen McShane, Priscille Brodin, Roland Brosch, Laleh Majlessi, Yper Hall, Stewart T. Cole and Claude Leclerc and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ann Williams

103 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis

2003 511 citations Priscille Brodin, Roland Brosch et al. profile →

Peers

Countries citing papers authored by Ann Williams

Since Specialization

Citations

This map shows the geographic impact of Ann Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Williams more than expected).

Fields of papers citing papers by Ann Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Williams. The network helps show where Ann Williams may publish in the future.

Co-authorship network of co-authors of Ann Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Williams. A scholar is included among the top collaborators of Ann Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Williams. Ann Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Culture-Free Enumeration of Mycobacterium tuberculosis in Mouse Tissues Using the Molecular Bacterial Load Assay for Preclinical Drug Development 2022 ·Microorganisms ·Dimitrios Evangelopoulos, Carolyn Shoen, Isobella Honeyborne, Simon Clark, Ann Williams, Galina V. Mukamolova, Michael H. Cynamon, Timothy D. McHugh	4
2	Pathogenomic analyses of Mycobacterium microti, an ESX-1-deleted member of the Mycobacterium tuberculosis complex causing disease in various hosts 2021 ·Microbial Genomics ·Mickael Orgeur, Wafa Frigui, Alexandre Pawlik, Simon Clark, Ann Williams, Louis S. Ates, Laurence Ma, Christiane Bouchier, Julian Parkhill, Priscille Brodin, Roland Brosch	17
3	High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation 2021 ·Scientific Reports ·Laura Sibley, Andrew White, Karen E. Gooch, (unknown), Rachel Tanner, (unknown), (unknown), Fergus Gleeson, Anthony McIntyre, Randall J. Basaraba, Simon Clark, Graham Hall, (unknown), Emma Rayner, Helen McShane, Ann Williams, Mike Dennis, Philip D. Marsh, Sally Sharpe	6
4	The TB vaccine development pathway – An innovative approach to accelerating global TB vaccine development 2020 ·Tuberculosis ·(unknown), Ann Williams, Bernard Fritzell, Dominick J. Laddy, (unknown), (unknown), Dereck Tait, Leo van der Pol, (unknown), (unknown), Jelle Thole, Gérald Voss, (unknown), Georges Thiry	8
5	Experimental animal modelling for TB vaccine development 2017 ·International Journal of Infectious Diseases ·Père-Joan Cardona, Ann Williams	30
6	A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis 2016 ·BMC Infectious Diseases ·Andrea Zelmer, Rachel Tanner, Elena Stylianou, Timon Damelang, Sheldon L. Morris, Angelo Izzo, Ann Williams, Sally Sharpe, Ilaria Pepponi, Barry Walker, David A. Hokey, Helen McShane, Michael J. Brennan, Helen A. Fletcher	26
7	Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb) 2013 ·Tuberculosis ·Leanne Marsay, Magali Matsumiya, Rachel Tanner, Hazel Poyntz, Kristin Griffiths, Elena Stylianou, Philip D. Marsh, Ann Williams, (unknown), Helen A. Fletcher, Helen McShane	38
8	Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials 2013 ·Vaccine ·Ainhoa Arbués, Nacho Aguiló, Jesús Gonzalo‐Asensio, Dessislava Marinova, Santiago Uranga, Eugenia Puentes, (unknown), Alberto Parra, Père-Joan Cardona, Cristina Vilaplana, V. Ausina, Ann Williams, Simon Clark, Wladimir Malaga, Christophe Guilhot, Brigitte Gicquel, Carlos Martı́n	190
9	Doxycycline and HIV Infection Suppress Tuberculosis-induced Matrix Metalloproteinases 2012 ·American Journal of Respiratory and Critical Care Medicine ·Naomi F. Walker, Simon Clark, Tolu Oni, Núria Andreu, Liku B. Tezera, Shivani Singh, Luísa Saraiva, Bernadette Pedersen, (unknown), Julia A. Tree, Jeanine D’Armiento, Graeme Meintjes, Francesco Mauri, Ann Williams, Robert J. Wilkinson, Jon S. Friedland, Paul Elkington	109
10	Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis 2012 ·Vaccine ·Michael J. Brennan, (unknown), (unknown), Vicki Chen, Ann Williams, Angelo Izzo, Lewellys F. Barker	54
11	Alloreactivity Across HLA Barriers Is Mediated by Both Naïve and Antigen-Experienced T Cells 2011 ·Biology of Blood and Marrow Transplantation ·J. Joseph Melenhorst, Phillip Scheinberg, Ann Williams, David R. Ambrozak, Keyvan Keyvanfar, Melody Smith, J. Philip McCoy, Nancy F. Hensel, Daniel C. Douek, A. John Barrett	25
12	Survival of Mycobacterium tuberculosis during experimental aerosolization and implications for aerosol challenge models 2011 ·Journal of Applied Microbiology ·Simon Clark, Yper Hall, (unknown), Graham Hatch, Ann Williams	36
13	Immunogenicity of orally-delivered lipid-formulated BCG vaccines and protection against Mycobacterium tuberculosis infection 2008 ·Microbes and Infection ·Julia Vipond, Martin L. Cross, Matthew R. Lambeth, Simon Clark, Frank E. Aldwell, Ann Williams	10
14	Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis 2008 ·Vaccine ·Simon Clark, Martin L. Cross, Alan M. Smith, (unknown), Julia Vipond, (unknown), R. Glyn Hewinson, Hannah Batchelor, Yvonne Perrie, Ann Williams, Frank E. Aldwell, Mark A. Chambers	12
15	Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31 2006 ·Vaccine ·Else Marie Agger, Ida Rosenkrands, Anja Weinreich Olsen, Graham Hatch, Ann Williams, (unknown), Karen Lingnau, Alexander von Gabain, (unknown), Karen Smith Korsholm, Peter Andersen	100
16	An assay to compare the infectivity of Mycobacterium tuberculosis isolates based on aerosol infection of guinea pigs and assessment of bacteriology 2004 ·Tuberculosis ·Ann Williams, Brian W. James, Joanna Bacon, Kim A. Hatch, Graham Hatch, Graham Hall, Philip D. Marsh	22
17	Characterization of Lung γδ T Cells Following Intranasal Infection with Mycobacterium bovis Bacillus Calmette-Guerin 2003 ·The Journal of Immunology ·Francesco Dieli, Juraj Iványi, Philip D. Marsh, Ann Williams, (unknown), Guido Sireci, Nadia Caccamo, Caterina Di Sano, Alfredo Salerno	88
18	Survival of mycobacterial species in aerosols generated from artificial saliva 2000 ·Letters in Applied Microbiology ·Mark S. Lever, Ann Williams, Allan Bennett	43
19	Cross-infection of chicks by airborne transmission of Salmonella enteritidis PT4 1996 ·Letters in Applied Microbiology ·Mark S. Lever, Ann Williams	29
20	Immunocytochemical demonstration of the association between Legionella pneumophila, its tissue‐destructive protease, and pulmonary lesions in experimental Legionnaires' disease 1987 ·The Journal of Pathology ·Ann Williams, A. Baskerville, A. B. Dowsett, J. Wayne Conlan	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact